Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

The Clorox Company $CLX Shares Purchased by Blume Capital Management Inc.

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Blume Capital Management increased its Clorox stake by 8,386.3% in the third quarter, bringing its holdings to 14,851 shares valued at approximately $1.2 million. Institutional investors collectively own 78.53% of CLX.
  • Analyst sentiment remains cautious: 12 analysts rate Clorox “Hold” and four rate it “Sell,” resulting in an average “Reduce” rating and a $93.57 price target.
  • Clorox shares opened at $86.78, while the company reported quarterly EPS of $1.66 and revenue of $1.95 billion. It declared a $1.25 quarterly dividend, equivalent to a 5.8% yield, despite a payout ratio above 100%.
  • Get every upgrade, downgrade, and earnings report on Clorox as it happens. Lock in MarketBeat All Access for $149 a year through October 30.

Blume Capital Management Inc. raised its holdings in The Clorox Company (NYSE:CLX - Free Report) by 8,386.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 14,851 shares of the company's stock after acquiring an additional 14,676 shares during the quarter. Blume Capital Management Inc.'s holdings in Clorox were worth $1,203,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Townsend & Associates Inc increased its stake in shares of Clorox by 41.4% in the third quarter. Townsend & Associates Inc now owns 20,963 shares of the company's stock valued at $1,698,000 after buying an additional 6,142 shares during the period. Sigma Planning Corp raised its position in shares of Clorox by 11.8% during the third quarter. Sigma Planning Corp now owns 37,175 shares of the company's stock worth $3,012,000 after acquiring an additional 3,916 shares during the last quarter. Probity Advisors Inc. raised its position in shares of Clorox by 9.0% during the third quarter. Probity Advisors Inc. now owns 6,334 shares of the company's stock worth $513,000 after acquiring an additional 525 shares during the last quarter. Radnor Capital Management LLC lifted its stake in shares of Clorox by 223.6% in the third quarter. Radnor Capital Management LLC now owns 9,424 shares of the company's stock worth $763,000 after acquiring an additional 6,512 shares during the period. Finally, Signaturefd LLC lifted its stake in shares of Clorox by 44.5% in the third quarter. Signaturefd LLC now owns 20,395 shares of the company's stock worth $1,796,000 after acquiring an additional 6,279 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently commented on CLX shares. Zacks Research upgraded Clorox from a "strong sell" rating to a "hold" rating in a report on Monday, September 14th. Weiss Ratings reissued a "hold (c-)" rating on shares of Clorox in a research report on Tuesday, October 6th. UBS Group set a $91.00 price target on shares of Clorox in a report on Thursday, October 15th. BNP Paribas Exane lowered their price target on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a report on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $95.00 price target on shares of Clorox in a research report on Monday, October 19th. Twelve analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Reduce" and an average price target of $93.57.

View Our Latest Report on CLX

Clorox Stock Up 0.4%

Shares of Clorox stock opened at $86.78 on Tuesday. The Clorox Company has a one year low of $79.12 and a one year high of $128.90. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The stock's 50-day moving average is $90.49 and its 200 day moving average is $100.42. The firm has a market cap of $10.50 billion, a price-to-earnings ratio of 18.00, a PEG ratio of 2.89 and a beta of 0.59.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The business had revenue of $1.95 billion during the quarter, compared to analysts' expectations of $1.91 billion. During the same quarter last year, the firm posted $2.87 earnings per share. The firm's revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Equities research analysts anticipate that The Clorox Company will post 5.66 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 5.8%. Clorox's dividend payout ratio (DPR) is 103.73%.

Clorox Company Profile

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines